The Efficacy and Safety of Inclisiran for Low-Density Lipoprotein (LDL) in Patients With Atherosclerotic Cardiovascular Disease (ASCVD): A Systematic Review of Randomized Controlled Trials.

Autor: Mirghani H; Internal Medicine, University of Tabuk, Tabuk, SAU., Albalawi BH; Surgery, King Khalid Hospital, Tabuk, SAU., Alshehri MS; Medicine, University of Tabuk, Tabuk, SAU., Almalawi WM; Internal Medicine, King Fahad Hospital (KFH), Tabuk, SAU., Alanezi S; Medicine and Surgery, University of Tabuk, Tabuk, SAU., Alarki M; College of Medicine, University of Tabuk, Tabuk, SAU., Alyahya AA; Medicine, University of Tabuk, Tabuk, SAU., Alshaman S; Medicine, University of Tabuk, Tabuk, SAU., Shaman MS; Medicine and Surgery, University of Tabuk, Tabuk, SAU., AlAnazi A; Medicine, College of Medicine, Tabuk University, Tabuk, SAU.

Publikováno v: Cureus [Cureus] 2024 Sep 28; Vol. 16 (9), pp. e70411. Date of Electronic Publication: 2024 Sep 28 (Print Publication: 2024).